AGT Knowledge Base

HIV / AIDS

Information in relation to HIV/AIDS including our clinical trial.

See all articles

About AGT103-T

AGT™ developed AGT103-T, a patented lentivirus designed to give CD4 T cells the ability to survive attack by HIV.

See all articles

Cancer Cure Program

AGT™ is creating genetic drugs that are designed to increase treatment potency, the immune system, broaden the types of cancers treated.

See all articles

General Questions

For questions unrelated to our therapeutics or our clinical trials

See all articles